Read this manager's filing book
Disclosed positions
PERCEPTIVE ADVISORS LLC: source evidence dated 2026-08-15T03:59:59.999Z.
- Issuer
- PRAXIS PRECISION MEDICINES I
- Ticker
- PRAX
- Class
- COM NEW
- Reported value
- $681,627,753
- Reported amount
- 2,035,986
- Unit
- SH
- Option
- None
The displayed owner or issuer and source fields identify the receipt to verify; keep reporting and availability dates separate.
What was reported for this quarter?
13F positions are dated quarter-end holdings, with later publication and possible amendments. Read report period and availability before calling them current.
SEC 13F-HR: 0001012975-26-000777Open the effective filing receipt and inspect shares, value and any put/call classification separately.
Browse institutional filings
Open the effective filing receipt and inspect shares, value and any put/call classification separately.
Browse institutional filingsKeep reporting dates and units beside the answer, and inspect its original citations.
Disclosed positions
See the complete disclosed positions
| PRAXIS PRECISION MEDICINES I | PRAX | COM NEW | $681,627,753 | 2,035,986 | SH | None |
| SPYRE THERAPEUTICS INC | SYRE | COM NEW | $383,484,855 | 4,319,496 | SH | None |
| CELCUITY INC | CELC | COM | $334,491,064 | 3,197,200 | SH | None |
| ASCENDIS PHARMA A/S | ASND | ORD SHS | $310,387,665 | 1,163,721 | SH | None |
| RHYTHM PHARMACEUTICALS INC | RYTM | COM | $287,156,334 | 2,586,295 | SH | None |
| ROIVANT SCIENCES LTD | ROIV | SHS | $286,144,465 | 8,085,461 | SH | None |
| RELAY THERAPEUTICS INC | RLAY | COM | $263,926,759 | 14,106,187 | SH | None |
| TRAVERE THERAPEUTICS INC | TVTX | COM | $213,183,729 | 3,752,574 | SH | None |
| KARDIGAN INC | KARD | COM | $195,585,788 | 8,200,662 | SH | None |
| NUVALENT INC | NUVL | COM | $195,192,368 | 1,580,505 | SH | None |
| EDGEWISE THERAPEUTICS INC | EWTX | COM | $177,714,564 | 4,373,974 | SH | None |
| APOGEE THERAPEUTICS INC | APGE | COM | $173,625,838 | 1,308,113 | SH | None |
| AMYLYX PHARMACEUTICALS INC | AMLX | COM | $149,694,481 | 8,334,882 | SH | None |
| MEIRAGTX HLDGS PLC | MGTX | COM | $145,727,749 | 10,786,658 | SH | None |
| ORUKA THERAPEUTICS INC | ORKA | COM | $128,009,646 | 1,345,063 | SH | None |
| INHIBRX BIOSCIENCES INC | INBX | COM | $122,963,044 | 1,297,763 | SH | None |
| PROTAGONIST THERAPEUTICS INC | PTGX | COM | $120,358,728 | 981,879 | SH | None |
| SOLID BIOSCIENCES INC | SLDB | COM NEW | $118,947,393 | 11,906,646 | SH | None |
| ZYMEWORKS INC | ZYME | COM | $109,342,391 | 4,182,953 | SH | None |
| TANGO THERAPEUTICS INC | TNGX | COM | $105,565,020 | 3,377,000 | SH | None |
| IMMATICS N.V | IMTX | SHS | $105,184,409 | 10,383,456 | SH | None |
| NURIX THERAPEUTICS INC | NRIX | COM | $104,813,438 | 4,320,422 | SH | None |
| BIOCRYST PHARMACEUTICALS INC | BCRX | COM | $103,088,880 | 10,308,888 | SH | None |
| REVOLUTION MEDICINES INC | RVMD | COM | $98,808,928 | 527,600 | SH | None |
| AVALYN PHARMACEUTICALS INC | AVLN | COM SHS | $88,070,744 | 2,675,296 | SH | None |
| MODERNA INC | MRNA | COM | $70,030,000 | 1,000,000 | SH | Put |
| DYNE THERAPEUTICS INC | DYN | COM | $59,727,909 | 2,689,235 | SH | None |
| BIOGEN INC | BIIB | COM | $59,669,938 | 276,173 | SH | None |
| IMMUNOVANT INC | IMVT | COM | $52,299,967 | 1,357,383 | SH | None |
| UNITEDHEALTH GROUP INC | UNH | COM | $48,548,078 | 116,806 | SH | None |
| SPDR SERIES TRUST | XBI | ST STR SP BIOT | $47,475,000 | 300,000 | SH | Put |
| IONIS PHARMACEUTICALS INC | IONS | COM | $44,878,140 | 566,000 | SH | None |
| SUTRO BIOPHARMA INC | STRO | COM SHS | $43,320,887 | 1,304,846 | SH | None |
| ALTO NEUROSCIENCE INC | ANRO | COM SHS | $42,485,076 | 1,609,893 | SH | None |
| JAZZ PHARMACEUTICALS PLC | JAZZ | SHS USD | $40,964,900 | 170,000 | SH | None |
| CORVUS PHARMACEUTICALS INC | CRVS | COM | $39,851,569 | 2,667,441 | SH | None |
| SIONNA THERAPEUTICS INC | SION | COM | $39,810,950 | 905,000 | SH | None |
| CYTOMX THERAPEUTICS INC. | CTMX | COM | $39,146,944 | 10,439,185 | SH | None |
| ARTIVION INC | AORT | COM | $39,036,906 | 1,737,290 | SH | None |
| X4 PHARMACEUTICALS INC | XFOR | COM NEW | $37,049,403 | 7,933,491 | SH | None |
| CORCEPT THERAPEUTICS INC | CORT | COM | $34,639,576 | 398,385 | SH | None |
| REPLIGEN CORP | RGEN | COM | $33,866,045 | 248,212 | SH | None |
| ANTERIS TECHNOLOGIES GLOBAL | AVR | COM | $33,740,939 | 3,425,476 | SH | None |
| RAPPORT THERAPEUTICS INC | RAPP | COM | $32,225,161 | 773,342 | SH | None |
| DAMORA THERAPEUTICS INC | DMRA | COM NEW | $31,810,230 | 1,223,000 | SH | None |
| CHARLES RIV LABS INTL INC | CRL | COM | $31,750,600 | 140,000 | SH | None |
| AXSOME THERAPEUTICS INC. | AXSM | COM | $28,993,007 | 118,450 | SH | None |
| EYEPOINT INC | EYPT | COM NEW | $28,600,000 | 2,000,000 | SH | Put |
| DBV TECHNOLOGIES S A | DBVT | SPONSORED ADS | $27,114,940 | 1,653,350 | SH | None |
| IRHYTHM HOLDINGS INC | IRTC | COM | $26,616,966 | 223,766 | SH | None |
No matching rows. Clear the filter to see all records.
Largest 50 positions by reported value; the filing may contain more positions.
How amendments affect these holdings
This view uses 1 effective filing version(s). A restatement replaces the previous book; a new-holdings amendment adds positions. 3 positions lack a resolved ticker and 7 positions are put or call entries.
A 13F is a delayed quarterly snapshot of disclosed holdings. It is not a complete trade ledger and does not reveal every position in a manager's portfolio. Option values refer to the reported underlying position rather than a traded option premium.
Quarter end and public filing date
Use the filing's public availability date when constructing a historical observation. The quarter-end report period is earlier and cannot be substituted for when the public learned the holdings.